S100P expression was then detected in tumor cell lines and carcinomas derived from the prostate, breast, colon, pancreas, and other tumor types, and it is associated with immortalized, malignant, hormone-independent, and chemoresistant phenotypes (13-15). The gene discussed is S100P; the disease is neoplasm.